Atara Biotherapeutics (ATRA) stock
Breakaway doesn't score ATRA. It is too thinly traded for a fair Quality Score.
Follow ATRA's news. Pro members can get an alert when Atara Biotherapeutics files news, and see its trials, share raises, and its CEO's filings.
We do the work for you. 3,168 stocks are scored and ranked, every 15 seconds while the market is open. Pro members see it live.
What's next for ATRA, and how long its cash lasts
Next step the company has named
Cash runway
About 1 quarter
Dilution on the horizon
- Shelf registration (S-3, filed Nov 10, 2026)
- At-the-market share sales program (S-3, filed Nov 10, 2026)
Insiders
Director Brian N Cherry bought 104,166 shares on Sep 4. 7 more insider trades this year.
FDA dates in the next 60 days
Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.
ATRA's latest filings
- Shelf registration, to sell securities later
- Quarterly report
- Atara Biotherapeutics Announces Third Quarter 2026 Financial Results and Operational Progress
Why ATRA isn't scored
The Quality Score reads US-listed stocks worth $50M or more that trade at $1 or more and 300,000 shares or $10M a day. ATRA trades about 24,000 shares a day. A stock that clears every mark is scored from the next weekly rebuild.
Straight AnswersStraight Answers
Are the prices delayed?
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.